kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Clinical policy

When we use compounded HRT — and when we don’t.

Compounded hormones are the engine of the menopause gold rush, sold on the implication that custom means better. It doesn’t. Here is exactly where compounding earns its place in Kindr protocols, and where an FDA-approved product wins.

Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026

The short version

“Bioidentical” describes a molecule, not a risk profile. Estradiol and micronized progesterone are bioidentical — and both are available as FDA-approved, batch-tested products. Compounded preparations are not tested by the FDA for safety, effectiveness, or consistency. So our default is the FDA-approved product, and compounding is reserved for a documented clinical reason. Anyone telling you compounded hormones are inherently safer is selling, not prescribing.

Where we prefer FDA-approved products

✓Transdermal estradiol patches, gels, and sprays at standard doses — FDA-approved products exist across the full dose range and carry pharmacokinetic data compounding cannot replicate.
✓Oral micronized progesterone for endometrial protection — an FDA-approved product with trial-level endometrial safety data.
✓Low-dose vaginal estrogen for genitourinary syndrome of menopause — creams, tablets, and rings are all commercially available.
✓Combination transdermal estradiol/progestin patches where a patient wants a single application.
✓Non-hormonal treatment of vasomotor symptoms — SSRIs/SNRIs, gabapentin, oxybutynin, and NK3-receptor antagonists such as fezolinetant.
✓GLP-1 receptor agonists where the branded product is accessible and affordable to the patient.

The five reasons we compound

Each of these is a clinical constraint, documented in the chart. None of them is “custom is better.”

1. Excipient or adhesive intolerance

A patient reacts to the adhesive in every commercially available patch, or to an excipient (peanut oil in some progesterone capsules, propylene glycol in some gels). A compounded base solves a real clinical problem.

2. A dose that is not commercially made

Titration sometimes lands between manufactured strengths, or a patient needs a very low starting dose after cancer treatment or a thrombotic event. Compounding allows a dose that a manufactured product cannot deliver.

3. A delivery form a patient can actually use

Swallowing difficulty, severe nausea, or dexterity limits can rule out capsules or patches. A cream or troche may be the difference between treatment and no treatment.

4. Female-physiologic testosterone

There is no FDA-approved testosterone product dosed for women in the United States. When testosterone is indicated for hypoactive sexual desire disorder in a postmenopausal woman, compounding — or careful fractional dosing of a male product — is the only route. We dose to the female physiologic range and monitor levels.

5. Access and cost of GLP-1 therapy

When a patient loses coverage or cannot afford branded semaglutide or tirzepatide, compounded therapy from a licensed 503A pharmacy can be the difference between treatment and abandonment. We say plainly that compounded GLP-1s are not FDA-approved drug products and carry less safety data than the branded originals. See our state-by-state GLP-1 coverage tracker.

What we will not prescribe

—Hormone pellets. Dosing cannot be adjusted or withdrawn once implanted, supra-physiologic estradiol and testosterone levels are common, and extrusion and infection are documented risks. We do not prescribe them at any price point.
—Compounded formulations marketed as "safer," "natural," or "bioidentical" in a way that implies superiority to FDA-approved therapy. Bioidentical describes molecular structure, not risk.
—Compounded estriol- or estrone-containing "Bi-Est" and "Tri-Est" blends prescribed on the claim that they are gentler than estradiol. There is no outcome evidence supporting that claim.
—Dosing driven by salivary hormone panels or by "hormone balancing" targets rather than symptoms and validated clinical thresholds.

The wider standards behind this policy — guideline sources, review cadence, and our outcomes-reporting commitment — are published on our clinical governance page.

Questions patients actually ask

Is compounded HRT the same as bioidentical HRT?

Not necessarily. "Bioidentical" means the hormone molecule is structurally identical to the one your body makes — estradiol and micronized progesterone are bioidentical, and both are available as FDA-approved products. Compounded means a pharmacy prepared the medication for an individual patient. A product can be bioidentical and FDA-approved, bioidentical and compounded, or neither.

Is compounded HRT safer than FDA-approved HRT?

No. Compounded preparations are not tested by the FDA for safety, effectiveness, or batch consistency. The Endocrine Society and The Menopause Society both state that FDA-approved products are preferred when a suitable one exists. Compounding is a solution to a specific clinical constraint, not an upgrade.

When does Kindr prescribe compounded hormones?

For excipient or adhesive intolerance, for doses or delivery forms not commercially manufactured, for female-physiologic testosterone (no FDA-approved option exists in the US), and for access-limited GLP-1 therapy. Every compounded prescription is documented with the clinical reason.

Does Kindr prescribe hormone pellets?

No. Pellet dosing cannot be adjusted or reversed after implantation and frequently produces supra-physiologic hormone levels. We do not offer them.

Which pharmacies does Kindr use?

FDA-registered, state-licensed 503A compounding pharmacies with LegitScript certification. Compounded medications are prepared per prescription for an individual patient and are not FDA-approved drug products.

Can I ask for an FDA-approved product instead?

Yes, and you should feel free to. Tell your clinician you prefer an FDA-approved formulation and they will use one wherever it is clinically appropriate.

Ask us which formulation you’re getting — and why.

Every Kindr prescription comes with the clinical reason behind it.

Start now

Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products. Compounded medications are not tested by the FDA for safety, effectiveness, or quality. Telehealth services are provided by licensed independent physicians. kindr is not a substitute for emergency or in-person care. First month pricing applies to new patients only. Individual results vary. Cancel anytime with 72-hour notice prior to next billing cycle. kindr.health is HIPAA Compliant. LegitScript certification pending.

Clinical protocols and prescribing overseen by Kindr Health Inc. NPI: 1609792902

Editorial & clinical review by the Kindr Health Editorial & Clinical Team · Last reviewed July 3, 2026.